このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

New In Situ Model Design for Caries and Erosion

2026年9月29日 更新者:Anderson T. Hara、Indiana University

Novel In Situ Caries and ETW Models Development: Safety and Validation Study

This study will test simultaneously and independently two novel in situ models, one for caries and one for erosive tooth wear (ETW), based on the simulation of these dental conditions on enamel specimens placed on 3D-printed mandibular appliances. Caries simulation will be done on the right side (color-coded blue) of the appliance, while ETW on the left side (color-coded red) and their outcomes evaluated independently. The study aims at testing the safety, compliance and F-efficacy (dose-response) of the models. The study will follow a double-blind, single-center, 3-way within-subject crossover design. Treatments will consist of dentifrices, or toothpastes, (1150 ppm F as sodium fluoride, 250 ppm F as sodium fluoride and 0 ppm F/Negative Control) used twice a day.

調査の概要

詳細な説明

The proposed in situ models have been designed for the study of dental caries and ETW, and to overcome some limitations associated to the models used at the Oral Health Research Institute. It is based on the removable intraoral mandibular appliance, to be used by participants with at least 20 teeth in the mouth, and targeting a younger adult population. The construction of the intraoral appliance will take advantage of the recent technology, precision and cost-efficiency associated to intraoral digital scanners and 3D metal printers. Wearing these appliances should be comfortable, as they rest passively in the cheek pouch and do not interfere with the habitual intercuspation of the teeth and phonetics. The investigators hypothesize the proposed in situ caries and ETW models to provide adequate treatment response broadly similar to our established caries and erosion in situ models, while expanding their utility, allowing long-term use and maintaining high subject compliance.

After study screening procedures are complete at the first study visit, a custom removable intraoral mandibular appliance will be made for each participant who is eligible to enroll in the study. Participants may need to return to the research site several times for appliance "try-in" visits prior to beginning the study procedures. Once a comfortable, well fitting appliance has been made, participants will proceed to study procedures.

Participants will progress through three treatment periods (each approximately 21 days in length). Each treatment period will require 5 study visits and at-home study procedures:

  • Prior to each treatment period, participants will attend a dental cleaning visit where a dental cleaning and oral examination will occur. At the end of the dental cleaning visit, participants will be provided with a fluoride free toothpaste to use at home for 2-3 days prior to the treatment initiation visit.
  • At each treatment initiation visit, 4 tooth specimens will be placed in each side of the intraoral appliance. Impressions will be made and stored for analysis. Participants will be provided with the first assigned toothpaste and at-home supplies.
  • During each 21 day treatment period, participants will use one of three study toothpastes, containing different fluoride levels, for the study directed twice daily brushing. Participants will be exposed to all three study toothpastes, however the treatment order sequence will be randomly assigned.
  • During each 21 day treatment period, participants will wear the dental appliance 24 hours per day except during meals/snacks and during at-home study directed procedures. Twice daily, participants will remove and brush the appliance according to study-specific directions. Four times daily, participants will remove and complete appliance challenge tasks in which the left and right sides of the appliance will be soaked in different solutions for 5 minutes at a time. Participants will return for evaluation at approximately 7, 14 and 21 days after each treatment period is initiated.
  • At the completion of each treatment period, participants will repeat the dental cleaning, treatment initiation, and day 7, 14, and 21 post-treatment initiation visits until all three study toothpastes have been used.

研究の種類

介入

入学 (実際)

12

段階

  • フェーズ 3

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Indiana
      • Indianapolis、Indiana、アメリカ、46202
        • Oral Health Research Institute of the Indiana University School of Dentistry

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~65年 (大人、高齢者)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

  • In order to participate subjects must:

    1. Provide voluntary, written informed consent;
    2. Be between 18 and 65 years old;
    3. Understand and be willing, able and likely to comply with all study procedures and restrictions;
    4. Be willing and capable of wearing a custom-made removable mandibular appliance 24 hours a day for three (3), three-week treatment periods;
    5. Be in good medical and dental health with no active caries or periodontal disease; Note: subjects presenting at screening with caries may continue in the study if their carious lesions are restored prior to beginning treatment 1; and,
    6. Have a salivary flow rate in the range of normal values (unstimulated whole saliva flow rate ≥ 0.2 mL/min; gum base stimulated whole saliva flow rate ≥ 0.8 mL/min);
    7. Have an adequate number of teeth and space to accommodate the custom-made removable mandibular appliance, as per the study PI/study dentist's discretion.

Exclusion Criteria:

  • No subject may:

    1. Be pregnant, intending to become pregnant during the study period or breast feeding;
    2. Have any medical condition that could be expected to interfere with the subject's safety during the study period (including temporomandibular disorders);
    3. Be taking antibiotics during the study period, or have taken antibiotics in the two weeks prior to the beginning treatment 1;
    4. Participated in another clinical study or receipt of an investigational drug within 30 days of beginning treatment 1;
    5. Be taking fluoride supplements, required to use a fluoride mouthrinse or have received a professional fluoride treatment in the two weeks preceding specimen placement; or,
    6. Have a history of metal allergies.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:基礎科学
  • 割り当て:ランダム化
  • 介入モデル:クロスオーバー割り当て
  • マスキング:トリプル

武器と介入

参加者グループ / アーム
介入・治療
プラセボコンパレーター:0 ppm F toothpaste

Participants will use toothpaste containing 0 ppm fluoride.

Toothpaste containing 0 ppm fluoride (F)

After impressions of both dental arches are taken, a mandibular appliance consisting of a 3D-printed metal frame and acrylic buccal flanges (blue on the right and red on the left) will be made. The appliance will be tested and adjusted for optimal fit and comfort before the experimental phase of the study. At each testing period, 4 gauze-covered 4-millimeter round partially demineralized human enamel specimens will be placed in the right buccal acrylic flange (blue, caries) side of the mandibular appliance and 4 sound human enamel specimens previously mounted on 3 millimeter round metal holders will be placed on the other acrylic flange (red, ETW) side of the same appliance. Subjects will wear their appliance 24 hours a day, except during study procedures, meals/snacks, and drinking (e.g. milk, juice, sports drinks, tea, etc.) except water.

アクティブコンパレータ:250 ppm F toothpaste

Participants will use toothpaste containing 250 ppm fluoride.

After impressions of both dental arches are taken, a mandibular appliance consisting of a 3D-printed metal frame and acrylic buccal flanges (blue on the right and red on the left) will be made. The appliance will be tested and adjusted for optimal fit and comfort before the experimental phase of the study. At each testing period, 4 gauze-covered 4-millimeter round partially demineralized human enamel specimens will be placed in the right buccal acrylic flange (blue, caries) side of the mandibular appliance and 4 sound human enamel specimens previously mounted on 3 millimeter round metal holders will be placed on the other acrylic flange (red, ETW) side of the same appliance. Subjects will wear their appliance 24 hours a day, except during study procedures, meals/snacks, and drinking (e.g. milk, juice, sports drinks, tea, etc.) except water.

Toothpaste containing 250 ppm fluoride, as NaF (sodium fluoride)

アクティブコンパレータ:1150 ppm F toothpaste

Participants will use toothpaste containing 1150 ppm fluoride.

After impressions of both dental arches are taken, a mandibular appliance consisting of a 3D-printed metal frame and acrylic buccal flanges (blue on the right and red on the left) will be made. The appliance will be tested and adjusted for optimal fit and comfort before the experimental phase of the study. At each testing period, 4 gauze-covered 4-millimeter round partially demineralized human enamel specimens will be placed in the right buccal acrylic flange (blue, caries) side of the mandibular appliance and 4 sound human enamel specimens previously mounted on 3 millimeter round metal holders will be placed on the other acrylic flange (red, ETW) side of the same appliance. Subjects will wear their appliance 24 hours a day, except during study procedures, meals/snacks, and drinking (e.g. milk, juice, sports drinks, tea, etc.) except water.

Marketed toothpaste product containing 1150 ppm fluoride, as NaF (sodium fluoride)

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Mean Percent Surface Microhardness (SMH) Recovery
時間枠:Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)

Description: The SMH test will be used to assess changes in the mineral status of partially demineralized enamel specimens. SMH will be measured using a Wilson 2100 Hardness Tester.

The extent of remineralization will be calculated based on the Gelhard et al. method of %SMH recovery = (D1-R)/(D1-B) x 100 where:

B = indentation length (µm, micrometer) of sound enamel specimen at baseline D1 = indentation length (µm) after in vitro demineralization R = indentation length (µm) after intra-oral exposure.

Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)
Surface Loss
時間枠:Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)

Measurements of enamel surface wear respective to the metal holder reference surfaces will be made on impressions of the specimens taken at baseline and after 7, 14 and 21 days of study. The impression of each specimen will be carefully cut with the aid of a scalpel and positioned on the profilometer with double adhesive tape for the scan. The parameters for the scan of both specimens and impressions will consist of step size set at 0.02 mm and number of steps at 200, in both x and y directions. The total area scanned will be 3 mm x 3 mm round specimens. With the use of dedicated software, the depth of the treated area will be calculated based on the reference surfaces. A 3-point height tool will be applied. Profile scans generated from impressions will be inverted (using the software) before analysis, in order to provide outcome data of surface loss (micrometers).

Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)

二次結果の測定

結果測定
メジャーの説明
時間枠
Mean Enamel Fluoride Uptake
時間枠:Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)

The Sakkab et al. microdrill enamel biopsy technique will be used to analyze the fluoride content of the partially demineralized enamel specimens. The amount of fluoride-uptake by enamel will be calculated based on the amount of fluoride divided by the area of the enamel cores and expressed as µg F/cm2.

Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)
Mean Net Acid Resistance
時間枠:Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)

To test whether the dentifrice imparts acid resistance to the enamel after 14 and 21 days of intra-oral exposure, a second in vitro demineralization will be repeated on the enamel specimens. SMH will be then evaluated by placing 5 indentations 100µm to the right of the indentations placed in situ remineralization. The %NAR will be calculated by the Corpron et al. method of % Net Acid Resistance = [(D1-D2) / (D1-B)] * 100 where:

B: Indentation length (µm) of sound enamel at baseline D1: Indentation length (µm) after first in vitro demineralization D2: Indentation length (µm) after second in vitro demineralization

Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)
Mean Comparative Acid Resistance
時間枠:Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)

This measure takes a different approach to understanding whether the enamel formed during remineralization is more resistant to acid than the original enamel. Using the data from the two enamel specimens, the equation used will compare explicitly the reduction in SMH brought by the first and second acid challenges:

  • Comparative Acid Resistance = [(D2-R) / (D1-B)] * 100 B: Indentation length (µm) of sound enamel at baseline R: Indentation length (µm) of enamel after in situ remineralization D1: Indentation length (µm) after first in vitro demineralization D2: Indentation length (µm) after second in vitro demineralization
Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)
Transervse Microradiography (TMR) - Integrated Mineral Loss
時間枠:Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)

Sections, approximately 100 µm in thickness, will be cut parallel to the orientation cut, after completion of the SMH analysis, using a Silverstone-Taylor Hard Tissue Microtome (Scientific Fabrications Laboratories, USA). The sections will be placed in the TMR-D system and X-rayed at 45 kV and 45 mA at a fixed distance for 12 s. An aluminum step wedge will be X-rayed under identical conditions. The digital images will be analyzed using the TMR software v.3.0.0.18. Sound enamel will be assumed to be 87% v/v mineral.

Lesions will be analyzed after in situ demineralization to calculate Integrated Mineral Loss (∆Z): [(lesion depth x 87) - area under the curve*]. *Area under the curve which relates volume % mineral at distances from the specimen surface with respect to section thickness.

Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)
Transverse Microradiography (TMR) - Lesion Depth
時間枠:Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)

Sections, approximately 100 µm in thickness, will be cut parallel to the orientation cut, after completion of the SMH analysis, using a Silverstone-Taylor Hard Tissue Microtome (Scientific Fabrications Laboratories, USA). The sections will be placed in the TMR-D system and X-rayed at 45 kV and 45 mA at a fixed distance for 12 s. An aluminum step wedge will be X-rayed under identical conditions. The digital images will be analyzed using the TMR software v.3.0.0.18. Sound enamel will be assumed to be 87% v/v mineral.

Lesions will be analyzed after in situ demineralization to calculate Lesion Depth (L): 83% mineral i.e. 95% of the mineral content of sound enamel.

Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)
Transverse Microradiography (TMR) - Maximum mineral density at the surface-zone
時間枠:Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)

Sections, approximately 100 µm in thickness, will be cut parallel to the orientation cut, after completion of the SMH analysis, using a Silverstone-Taylor Hard Tissue Microtome (Scientific Fabrications Laboratories, USA). The sections will be placed in the TMR-D system and X-rayed at 45 kV and 45 mA at a fixed distance for 12 s. An aluminum step wedge will be X-rayed under identical conditions. The digital images will be analyzed using the TMR software v.3.0.0.18. Sound enamel will be assumed to be 87% v/v mineral.

Lesions will be analyzed after in situ demineralization to calculate maximum mineral density at the surface-zone (SZmax).

Days 14 and 21 of each of the three consecutive treatment periods (each treatment period is 21 days)

その他の成果指標

結果測定
メジャーの説明
時間枠
Treatment Compliance
時間枠:Day 21 of each of three consecutive treatment periods (each treatment period is 21 days)

The number of participants demonstrating treatment compliance will be evaluated. Product use compliance will be assessed via the weight of the dispensed and returned test product tubes. The amount of test product used for each study treatment will be compared to daily product usage recorded on the subject's diary.

Also, the cariogenic/erosive challenge procedure completed will be assessed and significant discrepancies will be discussed with the study subject, as needed. Subjects who miss 15% or more treatments within the three-week treatment period will be considered non-compliant. The reason for non-compliance will be noted in the subject's study records.

Day 21 of each of three consecutive treatment periods (each treatment period is 21 days)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Anderson Hara, DDS, PhD、Indiana University

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年8月3日

一次修了 (推定)

2027年1月29日

研究の完了 (推定)

2027年1月29日

試験登録日

最初に提出

2026年8月31日

QC基準を満たした最初の提出物

2026年9月29日

最初の投稿 (実際)

2026年9月30日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月30日

QC基準を満たした最後の更新が送信されました

2026年9月29日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

キーワード

その他の研究ID番号

  • 31100

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

はい

米国FDA規制機器製品の研究

はい

米国で製造され、米国から輸出された製品。

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する